FIU Discovery

Paricalcitol Downregulates Myocardial ReninAngiotensin and Fibroblast Growth Factor Expression and Attenuates Cardiac Hypertrophy in Uremic Rats.  American Journal of Hypertension.  27:720-726.

Suppression of renin-angiotensin gene expression in the kidney by paricalcitol.  Kidney International.  74:1394-1402.

Apoptotic stress pathway activation mediated by iron on endothelial cells in vitro.  Nephrology Dialysis Transplantation.  21:3055-3061.

Increased osteoblastic activity and expression of receptor activator of NF-κB ligand in nonuremic nephrotic syndrome.  Journal of the American Society of Nephrology.  16:2198-2204.

Estrogen receptor (ER) gene polymorphism may predict the bone mineral density response to raloxifene in postmenopausal women on chronic hemodialysis.  Renal Failure.  27:155-161.

Outcomes associated with hypogonadism in women with chronic kidney disease.  Advances in Chronic Kidney Disease.  11:361-370.

Osteoporosis in chronic kidney disease.  American Journal of Kidney Diseases.  43:566-571.

Abnormalities of bone mineral density and bone metabolism in Venezuelan patients with rheumatoid arthritis.  Journal of Clinical Rheumatology.  9:219-227.

Bone remodeling after renal transplantation.  Kidney International.  63:S125-S128.

Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis.  Kidney International.  63:2269-2274.

Selective estrogen receptor modulators in chronic renal failure.  Kidney International.  63:S62-S65.

The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling.  Kidney International.  63:1915-1923.

The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study.  Clinical Endocrinology.  57:725-730.

Reduced bone mass in children with idiopathic hypercalciuria and in their asymptomatic mothers.  Nephrology Dialysis Transplantation.  17:1396-1401.

Decreased bone mineral density and bone formation markers - Shortly after diagnosis of clinical type 1 diabetes mellitus.  Journal of Pediatric Endocrinology and Metabolism.  14:525-528.

Access to medical information in Latin America.  The Lancet.  356:S15-S15.

Bone disease in patients with long-term renal transplantation and normal renal function.  American Journal of Kidney Diseases.  36:160-166.

Role of persistent amenorrhea in bone mineral metabolism of young hemodialyzed women.  Kidney International.  58:331-335.

Clinical algorithms on renal osteodystrophy.  Nephrology Dialysis Transplantation.  15:39-57.

Role of hormone replacement in the management of osteoporosis in haemodialysed women: perspectives for the future.  Nephrology Dialysis Transplantation.  15:36-37.

Bone disease after renal transplantation.  Transplantation Proceedings.  31:3033-3034.

Decreased bone mass despite long-term estrogen replacement therapy in young women with Turner's syndrome and previously normal bone density.  Fertility and Sterility.  72:896-899.

Latin American nephrology:: Scientific production and impact of the publications.  Kidney International.  56:1584-1590.

Decreased trabecular bone mineral density in children with idiopathic short stature: Normalization of bone density and increased bone turnover after 1 year of growth hormone treatment.  Journal of Pediatrics.  135:177-181.

Effect of recombinant human erythropoietin on endothelial cell apoptosis.  Kidney International.  55:546-553.

Bone loss in hypercalciuria: Cause or consequence?.  American Journal of Kidney Diseases.  33:XLVI-XLVIII.

Magnesium and phosphorus.  The Lancet.  352:391-396.

Bone Remodeling Factors in Children with Idiopathic Hypercalciuria (IH) and Osteopenia † 1801.  Pediatric Research.  43:307-307.

Decreased Bone Mass Despite Long Term Estrogen Replacement in Young Women with Turner's Syndrome (TS) and Previously Normal Bone Mineral Densities (BMD)† 449.  Pediatric Research.  43:79-79.

Decreased Bone Mineral Densities (BMD) and Bone Formation Markers During the First Year After Diagnosis of Insulin Dependent Diabetes Mellitus (IDDM) in Children. 431.  Pediatric Research.  43:76-76.

Osteopenia in Asymptomatic Premenopausal Mothers of Children with Idiopathic Hypercalciuria (IH) † 422.  Pediatric Research.  43:75-75.

Bone disease in hypercalciuria: a new form of osteodystrophy?.  Nephrology Dialysis Transplantation.  13:88-90.

What are the bone lesions in patients with more than four years of a functioning renal transplant?.  Nephrology Dialysis Transplantation.  13:103-104.

Role of the bone in the physiopathology of idiopathic hypercalciuria. Effect of aminobisphosphonate alendronate.  Medicina.  57:45-48.

Use of intrarenal needle manometry in acute renal dysfunction following renal transplantation.  Renal Failure.  19:227-230.

Changes in bone mineral density, growth velocity and renal function of prepuberal uremic children during growth hormone treatment.  Hormone Research in Paediatrics.  46:263-268.

Changes in bone mineral density (BMD) and total bone mineral content (BMC) in prepubertal children with marked short stature secondary to chronic renal failure (CRF): Effects of biosynthetic growth hormone (rhGH) therapy.  Osteoporosis International.  6:286-286.

Decreased trabecular bone mineral density (BMD) in children and adolescents with insulin dependent diabetes mellitus (IDDM).  Osteoporosis International.  6:286-286.

Interleukin-1α (IL-1α), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) mRNA expression in unstimulated peripheral blood mononuclear cells (PBMCs) in kidney stone patients with idiopathic hypercalciuria.  Osteoporosis International.  6:101-101.

Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria.  Kidney International.  49:244-250.

Role of the bone in the pathogenesis of idiopathic hypercalciuria (IH): Effect of aminobisphosphonate alendronate (ALN).  Osteoporosis International.  6:286-286.

[Impact of the Hospital Coordinator Program on obtaining kidneys for renal transplantation]..  Investigacion Clinica.  36:197-206.

BONE-MINERAL DENSITY OF PREPUBERTAL AGE GIRLS WITH TURNERS-SYNDROME WHILE ON GROWTH-HORMONE THERAPY.  Hormone Research in Paediatrics.  44:168-171.

OPTIMAL CUTOFF STRATEGIES IN CAPACITY EXPANSION PROBLEMS.  Naval Research Logistics.  42:1021-1039.

OCCULT REJECTION IN RENAL-ALLOGRAFTS - PRECONVERSION BIOPSIES AND POSTCONVERSION REJECTION IN RECIPIENTS CONVERTED FROM CYCLOSPORINE TO AZATHIOPRINE ALONE AT 6 TO 12 MONTHS AFTER TRANSPLANTATION.  Transplantation Proceedings.  26:333-334.

[Need and demand of kidneys for transplantation in Venezuela]..  Investigacion Clinica.  34:15-27.

IN CHRONIC UREMIA, INSULIN ACTIVATES RECEPTOR KINASE BUT NOT PYRUVATE-DEHYDROGENASE.  Nephron.  61:77-81.

Comparison of bone mineral content in hypercalciuric and normal children.  Bone and Mineral.  17:221.

Increased activity of protein kinase C in renal cortex during phosphate deprivation: Enhacement by parathyroid hormone administration in vivo.  Bone and Mineral.  17:111.

EFFECT OF ACIDOSIS ON PTH-DEPENDENT RENAL ADENYLATE-CYCLASE IN PHOSPHORUS DEPRIVATION - ROLE OF G PROTEINS.  The American journal of physiology.  258:F1640-F1649.

REGULATION OF 1,25-DIHYDROXYVITAMIN-D3 BY CALCIUM IN THE PARATHYROIDECTOMIZED, PARATHYROID HORMONE-REPLETE RAT.  Journal of Bone and Mineral Research.  4:929-935.

EFFECTS OF CHRONIC METABOLIC ALKALOSIS ON CA-2+, PTH, AND 1,25(OH)2D3 IN THE RAT.  The American journal of physiology.  257:E578-E582.

OPTIMAL LAYERED SEARCH.  Naval Research Logistics.  36:43-60.

INSULIN BINDING AND GLYCOLYTIC ACTIVITY IN ERYTHROCYTES FROM DIALYZED AND NONDIALYZED UREMIC PATIENTS.  Nephron.  48:190-196.

EFFECTS OF CADMIUM ON CANINE RENAL CORTICAL ADENYLATE-CYCLASE.  The American journal of physiology.  253:F401-F407.

MASSIVE CEREBRAL CALCIFICATIONS ASSOCIATED WITH INCREASED RENAL PHOSPHATE REABSORPTION.  Archives of Internal Medicine.  146:473-477.

EFFECT OF METABOLIC-ACIDOSIS ON THE PTH RECEPTOR-ADENYLATE CYCLASE SYSTEM OF CANINE KIDNEY.  The American journal of physiology.  249:F566-F572.

DIMENSIONS OF SPACES OF CUSP FORMS OVER FUNCTION-FIELDS.  Journal für die Reine und Angewandte Mathematik.  319:73-103.

EFFECT OF HEMODIALYSIS ON INSULIN-SECRETION BY ISOLATED ISLETS FROM MOUSE PANCREAS.  Acta Cientifica Venezolana.  29:473-478.

EVIDENCE THAT PARATHYROID-HORMONE IS NOT REQUIRED FOR PHOSPHATE HOMEOSTASIS IN RENAL-FAILURE.  Metabolism: Clinical and Experimental.  24:199-204.

EVIDENCE THAT HEMODIALYSIS DOES NOT IMPROVE GLUCOSE-TOLERANCE OF PATIENTS WITH CHRONIC RENAL-FAILURE.  Metabolism: Clinical and Experimental.  23:929-936.

NEPHROTIC SYNDROME - COMPLICATION OF MASSIVE OBESITY.  Annals of Internal Medicine.  81:440-447.

EFFECT OF DIALYSIS ON TRUE PLASMA GLUCOSE-TOLERANCE IN UREMIA.  Transactions - American Society for Artificial Internal Organs.  19:277-281.

PARADOXICAL EFFECT OF CHLORPROPAMIDE ON PLASMA GLUCOSE AND IMMUNOREACTIVE INSULIN-RESPONSE TO INTRAVENOUS GLUCOSE IN NORMAL DOGS.  Diabetes.  22:367-371.

COMPARISON OF EFFECTS OF METABOLIC-ACIDOSIS AND ACUTE UREMIA ON CARBOHYDRATE TOLERANCE.  Diabetes.  21:1109-+.

Group therapy in the rehabilitation of the severly aphasic and hemiplegic in the late stages..  Journal of Rehabilitation Medicine.  3:89-91.

Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally.  Journal of Pediatric Endocrinology and Metabolism.  11:413-419.

ESTIMATING VISUAL DETECTION PERFORMANCE AT SEA.  Operations Research.  36:651-659.

Nephrology in Venezuela.  201-218.

Early Bacteriological Diagnosis of Continuous Ambulatory Peritoneal Dialysis Peritonitis with the Use of a Cytocentrifuge.  223-226.

Response to Exogenous 1,25(OH)2D during a Low-Calcium Diet in Normal Subjects and Idiopathic Renal-Stone Formers.  611-613.

An Ambulatory Metabolic Study of Calcium Urolithiasis in Venezuela.  275-278.

The vitamin D analog paricalcitol (Pc) upregulates osteocyte fibroblast growth factor 23 (FGF23) and improves the mineralization defect in experimental uremia.  Bone. S241-S242.

Possible role of fibroblast growth factor 23 (FGF23) in the pathogenesis of osteodystrophy in end stage kidney disease and renal transplantation.  Osteoporosis International. S72-S72.

The spectrum of renal bone disease in chronic kidney disease (CKD) stages 3 to 5: Possible contribution of osteoporosis.  Osteoporosis International. S76-S77.

Calciuric response to an acute protein load in healthy subjects (C) and hypercalciuric (HQ and normocalciuric (NC) calcium stone formers..  Journal of the American Society of Nephrology. 702A-702A.

Effect of iron sucrose (Fe-S) and low molecular weight iron dextran (Fe-D) on endothelial cells (EC)..  Journal of the American Society of Nephrology. 872A-872A.

Possible role of fibroblast growth factor 23 (Fgf23) in the pathogenesis of osteodystrophy in end stage kidney disease and renal transplantation..  Journal of the American Society of Nephrology. 207A-207A.

Increased osteoblastic activity and expression of bone receptor activator of nuclear factor κB-ligand (RANKL) in non-uremic nephrotic syndrome (NS).  Pediatric Research. 521A-521A.

Increased expression of bone receptor activator of nuclear factor κB-ligand (RANK-L) in non-azotemic nephrotic syndrome (NS)..  Journal of the American Society of Nephrology. 9A-9A.

Increased in vitro stimulation of osteoblastic cells in non-azotemic Nephrotic Syndrome (NS)..  Journal of Bone and Mineral Research. S487-S487.

Inhibition of "in vitro" endothelial cell proliferation induced by iron sucrose..  Journal of the American Society of Nephrology. 340A-341A.

One year controlled trial of Pamidronate in the treatment of severe osteopenia after long term renal transplantation..  Journal of Bone and Mineral Research. S387-S387.

Role of hypophosphatemia in osteoblast apoptosis and impaired osteoblastogenesis in post-transplant bone disease. Protective role of PTH..  Journal of the American Society of Nephrology. 404A-404A.

Sex steroids and bone mass in male patients on chronic hemodialysis (HD): Positive association with serum estrogens and negative association with androgens..  Journal of the American Society of Nephrology. 404A-404A.

Effect of raloxifene, a selective estrogen receptor modulator (SERM), on bone resorption markers and serum lipids in postmenopausal women on chronic hemodialysis (HD).  Bone. S233-S233.

Osteoblastic stimulation and tumor necrosis factor-related activation-induced cytokine (TRANCE) expression in idiopathic hypercalciuria (IH).  Bone. S117-S117.

The pathogenesis of post-transplant (Tx) osteodystrophy as detected by early alterations in bone remodeling..  Bone. S117-S117.

In vitro stimulation of osteoblastic cells in idiopathic hypercalciuria (IH)..  Journal of Bone and Mineral Research. S358-S358.

The effect of raloxifene, a selective estrogen receptor modulator (SERM), on bone resorption markers and serum lipids in postmenopausal women on chronic hemodialysis..  Journal of Bone and Mineral Research. S435-S435.

Decreased trabecular bone mineral density in children with idiopathic short stature. Normalization of bone density and increased bone turnover after one year of growth hormone treatment.  Pediatric Research. 93A-93A.

Analysis of continuous ambulatory peritoneal dialysis (CAPD) patient's permanence: Patient versus technique survival?.  Journal of the American Society of Nephrology. A0825-A0825.

Bone disease in patients with normal renal function after long-term renal transplantation (RTx)..  Journal of the American Society of Nephrology. A2557-A2557.

Reduced bone mass in asymptomatic mothers and their children with idiopathic hypercalciuria (IH)..  Journal of the American Society of Nephrology. A2567-A2567.

Bone mineral density (BMD) and bone metabolism in children and adolescents with insulin dependent diabetes mellitus (IDDM)..  Journal of Bone and Mineral Research. S652-S652.

Role of the bone in the pathophysiology of idiopathic hypercalciuria: Effect of long term alendronate (ALN) administration..  Journal of Bone and Mineral Research. T694-T694.

A controlled, long term study on the effect of alendronate (ALN) in idiopathic hypercalciuria..  Journal of the American Society of Nephrology. A2697-A2697.

Decreased trabecular bone mineral density (BMD) and hypercalciuria in children and adolescents with insulin dependent diabetes mellitus (IDDM)..  Journal of the American Society of Nephrology. A2722-A2722.

Effect of recombinant human erythropoietin (rHuEPO) on apoptosis in endothelial cells (EC)..  Journal of the American Society of Nephrology. A1548-A1548.

Role of protein kinase (PKC) on the mechanism of PTH resistance in phosphate deprivation..  Journal of the American Society of Nephrology. A2786-A2786.

ROLE OF THE BONE IN THE PATHOGENESIS OF IDIOPATHIC HYPERCALCIURIA - EFFECT OF AMINOBISPHOSPHONATE ALENDRONATE (ALN).  Journal of the American Society of Nephrology. 933-933.

IMPORTANCE OF BUN REBOUND (R) IN ASSESSING DIALYSIS PRESCRIPTION.  Journal of the American Society of Nephrology. 515-515.

THROMBOMODULIN (TM) LEVELS IN UNTREATED UREMIA (UU), HEMODIALYSIS (HD), AND CHRONIC AMBULATORY PERITONEAL-DIALYSIS (CAPD).  Journal of the American Society of Nephrology. 431-431.

COMPARISON OF BONE-MINERAL CONTENT IN HYPERCALCIURIC AND NORMAL-CHILDREN.  Kidney International. 1421-1422.

VALUE OF THE INTRARENAL PRESSURE DETERMINATION (IRP) IN THE MANAGEMENT OF RENAL-FAILURE AFTER KIDNEY-TRANSPLANTATION.  Kidney International. 1421-1421.

SOME ASPECTS OF THE PATHOPHYSIOLOGY OF CALCIUM NEPHROLITHIASIS.  International Congress Series. 61-68.

EFFECTS OF MAGNESIUM ON THE REGULATION OF PARATHYROID HORMONE-DEPENDENT ADENYLATE-CYCLASE.  716-721.

MODULATION OF URINARY CITRATE EXCRETION (UCI) BY PROMOTING FACTORS OF IDIOPATHIC URINARY LITHIASIS.  60-62.

RESISTANCE OF ADENYLATE-CYCLASE (AC) TO PTH DURING PHOSPHATE DEPRIVATION (PD) IS ASSOCIATED TO DECREASED ACTIVITY OF THE STIMULATORY SIGNAL TRANSDUCING GS.  Kidney International. 463-463.

SLOWER PROGRESSION OF BONE MASS-LOSS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS (CAPD) AS COMPARED TO CHRONIC-HEMODIALYSIS (HD).  Kidney International. 334-334.

PATHOGENESIS, MEDICAL-TREATMENT AND PREVENTION OF CALCIUM-OXALATE RENAL STONES.  107-110.

PHARMACOLOGICAL AND NONPHARMACOLOGICAL REGULATION OF SODIUM-PHOSPHATE COTRANSPORT IN THE KIDNEY.  125-128.

RESPONSE TO EXOGENOUS 1,25(OH)2 D3 (1,25D) IN IDIOPATHIC RENAL STONE FORMERS.  Kidney International. 400-400.

ERYTHROPOIESIS AND ERYTHROPOIETIN BLOOD-LEVELS (EP) IN RATS WITH RENAL-FAILURE (RF) AND INDUCED ANEMIA.  Kidney International. 372-372.

METABOLIC-ACIDOSIS (MA) ENHANCES THE RESISTANCE OF CANINE RENAL CORTICAL ADENYLATE-CYCLASE (AC) TO PARATHYROID-HORMONE (PTH) DURING DIETARY PHOSPHORUS DEPRIVATION (PD).  Kidney International. 335-335.

RESPONSE TO EXOGENOUS 1,25(OH)2 VITAMIN-D3 (1,25D) UNDER A LOW-CALCIUM DIET IN NORMAL CONTROLS AND IDIOPATHIC RENAL STONE FORMERS.  Urolithiasis. 202-203.

INTERACTION OF CADMIUM (CD++) WITH THE PTH-ADENYLATE CYCLASE (AC) SYSTEM IN BASOLATERAL CORTICAL MEMBRANES OF CANINE KIDNEY.  Kidney International. 173-173.

REGULATION OF SERUM 1,25(OH)2D3 BY IONIZED CALCIUM DURING CONSTANT PHYSIOLOGICAL REPLACEMENT OF PARATHYROID-HORMONE IN THE PARATHYROIDECTOMIZED RAT.  Kidney International. 360-360.

IONIZED CALCIUM REGULATES SERUM 1,25(OH)2D3 DURING CONSTANT PHYSIOLOGICAL REPLACEMENT OF PARATHYROID-HORMONE IN THE PARATHYROID-ECTOMIZED RAT.  Clinical Research. A967-A967.

EFFECT OF CADMIUM ON THE ADENYLATE-CYCLASE SYSTEM OF CANINE KIDNEY.  Clinical Research. A602-A602.

RELATIONSHIP BETWEEN GLYCOLYTIC ACTIVITY IN ERYTHROCYTES AND GLUCOSE-INTOLERANCE IN UREMIA (U), HEMODIALYSIS(HD), AND CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD).  Kidney International. 243-243.

PROSPECTIVE AMBULATORY METABOLIC STUDY OF IDIOPATHIC CALCIUM NEPHROLITHIASIS IN VENEZUELA.  Urolithiasis. 31-31.

EFFECT OF PARATHYROID-HORMONE (PTH) REDUCTION BY CIMETIDINE ON THE GLUCOSE-INTOLERANCE OF UREMIA.  Kidney International. 217-217.

INSULIN-SECRETION FROM ISOLATED ISLETS CELLS OBTAINED FROM UREMIC RATS.  Kidney International. 228-228.

INSULIN-SECRETION FROM ISOLATED PANCREATIC-ISLETS OBTAINED FROM UREMIC RATS.  Clinical Research. A465-A465.

EFFECT OF UREMIA ON INSULIN-SECRETION BY ISOLATED PANCREATIC-ISLETS.  Acta Cientifica Venezolana. 86-86.

COMPARATIVE EFFECTS OF HEMODIALYSIS AND PERITONEAL-DIALYSIS ON GLUCOSE-INTOLERANCE IN UREMIA.  Acta Cientifica Venezolana. 64-64.

EFFECT OF HEMODIALYSIS ON INSULIN-SECRETION FROM ISOLATED PANCREATIC-ISLETS CELLS.  Kidney International. 493-493.

EFFECT OF HEMODIALYSIS ON INSULIN-SECRETION INVITRO OF ISOLATED MOUSE PANCREATIC-ISLETS.  Acta Cientifica Venezolana. 77-77.

Renal function and bisphosphonate safety.  Journal of Bone and Mineral Research. 453-454.

Magnesium and phosphorus -: Reply.  The Lancet. 1475-1476.

CLINICAL AND HISTOLOGICAL KIDNEY INVOLVEMENT IN HUMAN KALAAZAR.  American Journal of Tropical Medicine and Hygiene. 357-359.

THE COMPLEXITY OF THE OPTIMAL SEARCHER PATH PROBLEM.  Operations Research. 324-327.

Abdominal Pain in a Patient with Asymmetry.  Kidney 360. 314-315.

Clinical Practice Guidelines for the Prevention, Diagnosis, Evaluation and Treatment of Mineral and Bone Disorders in Chronic Kidney Disease (CKD-MBD) in Adults (vol 33, pg 1, 2013).  Nefrologia. 868-868.

Foreword.  Kidney International. S1-S2.

Bone mineral density in idiopathic hypercalciuria: The chicken or the egg?.  Nephron. C81-C82.

New insights into the pathogenesis of idiopathic hypercalciuria: The role of bone.  Kidney International. 1507-1518.

[Safety in the switching traditional cyclosporin to microemulsion cyclosporin in stable renal transplant patients: cooperative study]..  Investigacion Clinica. 183-196.

Massive cerebral calcifications associated with increased renal phosphate reabsorption..  Archives of Internal Medicine. 473-477.

Insulin and glucose metabolism in renal insufficiency..  Kidney International, Supplement. 63-69.

Introduction and definition of CKD-MBD and the development of the guideline statements.  Kidney International. S3-S130.

Bone disease after renal transplantation.  American Society of Nephrology. Clinical Journal. 1300-1313.

Bone disease in idiopathic hypercalciuria.  Current Opinion in Nephrology and Hypertension. 394-402.

Postmenopausal osteoporosis in the dialysis patient.  Current Opinion in Nephrology and Hypertension. 381-386.

A SURVEY OF THE SEARCH THEORY LITERATURE.  Naval Research Logistics. 469-494.